Graber CJ, Wong MK, Carleton HA, Perdreau-Remington F, Haller BL, Chambers HF
Intermediate vancomycin susceptibility in a community-associated MRSA clone. [Journal Article]
Emerg Infect Dis 2007 Mar; 13(3):491-3.
We describe a case of treatment failure caused by a strain of USA300 community-associated methicillin-resistant Staphylococcus aureus (MRSA) with intermediate susceptibility to vancomycin and reduced susceptibility to daptomycin. The strain was isolated from the bone of a 56-year-old man with lumbar osteomyelitis after a 6-week treatment course of vancomycin for catheter-associated septic thrombophlebitis.
More from this journal |
